Clinical Trial: A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421297) titled 'A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia' on Feb. 12.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of SYH2053 monotherapy in patients with primary hypercholesterolemia (non-familial) or mixed dyslipidemia .

This trial plans to enroll 900 Participants.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Intervention: DRUG: SYH2053/placebo injection

Participants receive SYH2053/placebo injection by subcutaneous...